Hypofractionated stereotactic re-irradiation with pembrolizumab and bevacizumab in patients with recurrent high-grade gliomas: results from a phase I study.
Neuro Oncol. 2021 Apr 12;23(4):677-686. doi: 10.1093/neuonc/noaa260.
Neuro Oncol. 2021.
PMID: 33173935
Free PMC article.
Clinical Trial.